MonumenTAL-8
A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
Arms / Cohorts
Experimental - RRMM:Cohort 1: Cilta-cel + Talquetamab Consolidation Post Chimeric Antigen Receptor T cell (CAR-T)Therapy
Not yet accepting
Experimental - NDMM:Cohort 2: Cilta-cel + Talquetamab Consolidation Post CAR-T Therapy
Not yet accepting
Experimental - RRMM:Cohort 3: Tal Bridging Therapy Pre-CAR-T Therapy + Cilta-cel
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.